慢性硬膜下血肿钻孔引流后复发时间与危险因素:cSDH-Drain随机对照试验亚组分析
该亚组分析纳入cSDH-Drain随机对照试验的220例患者,比较骨膜下引流(SPD)与硬膜下引流(SDD)后复发时间及危险因素。中位复发时间22.5天,两组无差异;多因素分析显示仅术中脑膨胀不足(iBE)为复发独立危险因素。
要点
- SPD与SDD两组中位复发时间无差异,均为22.5天。
- 多因素分析显示术中脑膨胀不足是复发的唯一独立危险因素。
- SPD不增加复发风险,常规临床可考虑使用。
核心结论
- 引流管类型不影响慢性硬膜下血肿钻孔引流后的复发时间。
- 术中脑膨胀不足是复发的独立危险因素。
- SPD可独立于患者、手术或血肿特征用于常规临床实践。
研究设计与样本
- 对cSDH-Drain随机对照试验的亚组分析,纳入220例患者。
- 比较SPD与SDD两组复发时间,采用单因素Cox比例风险模型。
- 通过单因素和多因素分析评估术前、术中及术后复发危险因素。
主要发现
- 中位复发时间为22.5天(四分位距9.25-52天,范围0-81天),两组无差异。
- 单因素分析显示术中脑膨胀不足(P=0.019)、出院时GOS评分较低(P=0.007)和24小时GCS评分较低(P=0.037)与复发强相关。
- 多因素logistic分析显示仅术中脑膨胀不足(OR=1.10,95%CI 1.01-1.21,P=0.03)为复发独立危险因素。
- 在SDD组中,术中脑膨胀不足和出院时GOS评分较低与复发相关。
临床怎么用
- SPD可用于慢性硬膜下血肿钻孔引流,不增加复发风险。
- 术中应关注脑膨胀情况,膨胀不足提示复发风险增高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The randomized controlled Chronic Subdural Hematoma (cSDH)-Drain-Trial showed comparable recurrence rates after placing a subperiosteal drain (SPD) or a subdural drain (SDD) for surgically drained cSDH, although SDD was associated with higher rates of infection and iatrogenic brain injury. This subanalysis examines the time to recurrence and possible risk factors for recurrence after burr-hole drainage of cSDH and placement of a SPD compared with a SDD. METHODS: We included 220 patients from the preceding cSDH-Drain-Trial. Time to recurrence was compared within the 2 groups using a univariate Cox proportional hazards model. Apart from intraoperative brain expansion (iBE), defined by residual hematoma-cavity on computer tomography 24 hours after surgery, other possible pre-, intra- and postoperative risk factors for recurrence were assessed through univariate and multivariate analysis. RESULTS: Median time to recurrence was 22.5 days (interquartile range: 9.25-52 days, range: 0-81) showing no difference between the 2 groups. Less iBE (P = 0.019), lower Glasgow Outcome Scale score at discharge (P = 0.007), and lower Glasgow Coma Scale score at 24 hours (P = 0.037) were strongly associated with recurrence on univariate analysis. After multivariate logistic analysis, less iBE (odds ratio: 1.10, 95% CI: 1.01; 1.21; P = 0.03) remained the only significant risk factor associated with recurrence. When comparing the risk factors within the 2 groups, less iBE and lower Glasgow Outcome Scale score at release were associated with recurrence only in the SDD group. CONCLUSIONS: The inserted drain type after burr-hole drainage of cSDH does not seem to influence time to recurrence. SPD may be warranted in routine clinical practice, independent of individual patient, surgical, or hematoma characteristics.
引用
- Lutz K, Kamenova M, Schaedelin S, et al. Time to and Possible Risk Factors for Recurrence after Burr-hole Drainage of Chronic Subdural Hematoma: A Subanalysis of the cSDH-Drain Randomized Controlled Trial. World Neurosurg. 2019. PMID: 31479790. doi:10.1016/j.wneu.2019.08.175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。